Founded over 35 years ago, the Equasens Group is an expert in business software solutions for healthcare professionals and institutions.
Equasens is also involved in the design of electronic equipment, digital and robotic healthcare solutions, as well as in financing.
Today, Equasens equips all types of healthcare establishments - EHPAD, hospitals, SSIAD, HAD, CPTS, MSP - and private healthcare professionals such as pharmacists, doctors and nurses.
In addition to these activities, the Group specializes in interoperability solutions to improve the coordination of healthcare professionals and the exchange of patient data.
The Equasens Group is the leading healthcare software publisher in terms of market share and diversity of businesses.
The Group is a key player in the healthcare sector and in town-hospital coordination. It is present in France, Italy, Germany, Spain, Portugal, Belgium, Luxembourg and the United Kingdom.
Europe
Headquarters5 Allée de Saint-Cloud, 54600 Villers-lès-Nancy – France
Line item in (eur) | 01.01.2020 | 02.01.2020 | 01.01.2021 | 02.01.2021 | 01.01.2022 | 02.01.2022 | 01.01.2023 |
---|---|---|---|---|---|---|---|
Assets | N/A | N/A | 295,777,000.00 | N/A | 329,950,000.00 | N/A | 350,812,000.00 |
Noncurrent Assets | N/A | N/A | 184,904,000.00 | N/A | 207,696,000.00 | N/A | 213,639,000.00 |
Property Plant And Equipment | N/A | N/A | 27,456,000.00 | N/A | 27,661,000.00 | N/A | 26,610,000.00 |
Goodwill | N/A | N/A | 65,552,000.00 | N/A | 83,693,000.00 | N/A | 83,069,000.00 |
Intangible Assets Other Than Goodwill | N/A | N/A | 36,628,000.00 | N/A | 39,476,000.00 | N/A | 38,455,000.00 |
Investment Accounted For Using Equity Method | N/A | N/A | 8,431,000.00 | N/A | 7,671,000.00 | N/A | 7,994,000.00 |
Deferred Tax Assets | N/A | N/A | 2,337,000.00 | N/A | 2,379,000.00 | N/A | 2,544,000.00 |
Current Assets | N/A | N/A | 110,873,000.00 | N/A | 122,254,000.00 | N/A | 137,173,000.00 |
Cash and cash equivalents | N/A | 21,366,000.00 | 33,630,000.00 | 33,630,000.00 | 34,812,000.00 | 34,812,000.00 | 23,436,000.00 |
Equity And Liabilities | N/A | N/A | 295,777,000.00 | N/A | 329,950,000.00 | N/A | 350,812,000.00 |
Equity | 131,912,000.00 | 131,912,000.00 | 148,953,000.00 | 148,953,000.00 | 165,236,000.00 | 165,236,000.00 | 196,797,000.00 |
Issued Capital | N/A | N/A | 3,035,000.00 | N/A | 3,035,000.00 | N/A | 3,035,000.00 |
Retained Earnings Profit Loss For Reporting Period | N/A | N/A | N/A | N/A | 39,119,000.00 | N/A | 46,376,000.00 |
Equity Attributable To Owners Of Parent | N/A | N/A | 143,257,000.00 | N/A | 159,005,000.00 | N/A | 189,776,000.00 |
Noncontrolling Interests | N/A | N/A | 5,696,000.00 | N/A | 6,230,000.00 | N/A | 7,021,000.00 |
Noncurrent Liabilities | N/A | N/A | 65,458,000.00 | N/A | 70,651,000.00 | N/A | 55,872,000.00 |
Noncurrent Provisions | N/A | N/A | 5,264,000.00 | N/A | 5,536,000.00 | N/A | 5,632,000.00 |
Deferred Tax Liabilities | N/A | N/A | 855,000.00 | N/A | 1,406,000.00 | N/A | 1,517,000.00 |
Other Noncurrent Liabilities | N/A | N/A | 4,329,000.00 | N/A | 325,000.00 | N/A | 95,000.00 |
Current Liabilities | N/A | N/A | 81,366,000.00 | N/A | 94,063,000.00 | N/A | 98,142,000.00 |
Current Provisions | N/A | N/A | 252,000.00 | N/A | 724,000.00 | N/A | 552,000.00 |
Other Current Liabilities | N/A | N/A | 49,309,000.00 | N/A | 54,266,000.00 | N/A | 61,245,000.00 |
Line item in (eur) | 01.01.2020/ 01.01.2021 |
01.01.2020/ 01.01.2022 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
---|---|---|---|---|
Revenue | 171,754,000.00 | N/A | 193,069,000.00 | 214,075,000.00 |
Interest Income On Cash And Cash Equivalents | N/A | N/A | 921,000.00 | 1,613,000.00 |
Other Income | 0.00 | N/A | 0.00 | 0.00 |
Raw Materials And Consumables Used | 32,237,000.00 | N/A | 36,888,000.00 | 40,748,000.00 |
Services Expense | 20,212,000.00 | N/A | 22,365,000.00 | 27,805,000.00 |
Employee Benefits Expense | 60,854,000.00 | N/A | 68,682,000.00 | 74,215,000.00 |
Depreciation And Amortisation Expense | 9,015,000.00 | N/A | 11,328,000.00 | 12,299,000.00 |
Tax Expense Other Than Income Tax Expense | 3,479,000.00 | N/A | 2,938,000.00 | 3,047,000.00 |
Profit Loss From Operating Activities | 46,134,000.00 | N/A | 50,265,000.00 | 55,213,000.00 |
Finance Income | 1,340,000.00 | N/A | 921,000.00 | N/A |
Finance Costs | 571,000.00 | N/A | 589,000.00 | N/A |
Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | 119,000.00 | N/A | -79,000.00 | 367,000.00 |
Income Tax Expense Continuing Operations | 13,397,000.00 | N/A | 10,621,000.00 | 6,179,000.00 |
Profit Loss From Continuing Operations | 32,666,000.00 | N/A | 41,150,000.00 | 48,573,000.00 |
Profit Loss From Discontinued Operations | 0.00 | N/A | 0.00 | 127,000.00 |
Profit (loss) | 32,666,000.00 | 32,666,000.00 | 41,150,000.00 | 48,700,000.00 |
Profit Loss Attributable To Owners Of Parent | 30,714,000.00 | N/A | 39,119,000.00 | 46,376,000.00 |
Profit Loss Attributable To Noncontrolling Interests | 1,951,000.00 | N/A | 2,031,000.00 | 2,324,000.00 |
Line item in (eur) | 01.01.2021 | 01.01.2022 | 02.01.2020 | 02.01.2021 | 01.01.2023 | 02.01.2022 |
---|---|---|---|---|---|---|
Profit (loss) | 32,666,000.00 | 41,150,000.00 | N/A | N/A | 48,700,000.00 | N/A |
Adjustments For Reconcile Profit Loss | 26,000.00 | 352,000.00 | N/A | N/A | 352,000.00 | N/A |
Adjustments For Decrease Increase In Inventories | -702,000.00 | -2,095,000.00 | N/A | N/A | -438,000.00 | N/A |
Adjustments For Increase Decrease In Trade Account Payable | -1,215,000.00 | 1,817,000.00 | N/A | N/A | 506,000.00 | N/A |
Other Adjustments For Noncash Items | 0.00 | 0.00 | N/A | N/A | 0.00 | N/A |
Adjustments For Losses Gains On Disposal Of Noncurrent Assets | 156,000.00 | 14,000.00 | N/A | N/A | -114,000.00 | N/A |
Adjustments For Reconcile Profit Loss | 26,000.00 | 352,000.00 | N/A | N/A | 352,000.00 | N/A |
Cash Flows From Used In Operations | 27,601,000.00 | 37,182,000.00 | N/A | N/A | N/A | N/A |
Interest Paid Classified As Operating Activities | 571,000.00 | 589,000.00 | N/A | N/A | 679,000.00 | N/A |
Cash Flows From Used In Operating Activities | 47,209,000.00 | 47,516,000.00 | N/A | N/A | 56,977,000.00 | N/A |
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | 13,645,000.00 | 20,119,000.00 | N/A | N/A | 17,522,000.00 | N/A |
Proceeds From Other Longterm Assets Classified As Investing Activities | 0.00 | 0.00 | N/A | N/A | 0.00 | N/A |
Purchase Of Other Longterm Assets Classified As Investing Activities | 0.00 | 0.00 | N/A | N/A | 0.00 | N/A |
Other Inflows Outflows Of Cash Classified As Investing Activities | 49,000.00 | -91,000.00 | N/A | N/A | -99,000.00 | N/A |
Proceeds From Changes In Ownership Interests In Subsidiaries | 0.00 | 0.00 | N/A | N/A | 0.00 | N/A |
Proceeds From Issuing Shares | 0.00 | 0.00 | N/A | N/A | 0.00 | N/A |
Payments To Acquire Or Redeem Entitys Shares | 0.00 | 5,156,000.00 | N/A | N/A | 1,068,000.00 | N/A |
Payments Of Other Equity Instruments | N/A | 0.00 | N/A | N/A | 0.00 | N/A |
Proceeds From Borrowings Classified As Financing Activities | 22,155,000.00 | 26,910,000.00 | N/A | N/A | 7,829,000.00 | N/A |
Repayments Of Borrowings Classified As Financing Activities | 11,564,000.00 | 15,243,000.00 | N/A | N/A | 17,847,000.00 | N/A |
Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -34,000.00 | 64,000.00 | N/A | N/A | -81,000.00 | N/A |
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | 12,197,000.00 | 1,590,000.00 | N/A | N/A | 281,000.00 | N/A |
Cash and cash equivalents | 33,630,000.00 | 34,812,000.00 | 21,366,000.00 | 33,630,000.00 | 23,436,000.00 | 34,812,000.00 |
Please note that some sums might not add up.
FR0012882389
LEI96950066I7XVFGZI8L92
SectorKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.